It’s been two years since Gorillaz’s latest album, Cracker Island. Since then, the band shared a deluxe version featuring ...

Nothing has been confirmed yet, but if Black Panther 3 is made, Marvel Phase 6 would be a surprise. But, then again, there are release slots to fill, and Black Panther is a pivotal character and ...

After years of shows and movies, Marvel Phase 5 is almost over ... Guardians of the Galaxy 3 marked the last chapter in the Guardians of the Galaxy story. And it's certainly an emotional send ...

Egypt is calling for $53bn to fund the reconstruction of Gaza, with the money distributed over three phases. In the first six-month phase it would cost $3bn to clear rubble from Salah al-Din ...

Lex­i­con Phar­ma­ceu­ti­cals’ non-opi­oid drug has failed a mid-stage test in a chron­ic pain in­di­ca­tion — but the com­pa­ny says there’s still a path for­ward and even … ...

Rusfertide was already undergoing the pivotal phase 3 VERIFY trial, and Takeda announced this morning that the study has hit its primary endpoint. Patients with PV are at increased risk from life ...

--(BUSINESS WIRE)--Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) today announced positive topline results for the Phase 3 VERIFY study, in which ...

BioXcel Therapeutics (BTAI) announced that the U.S. Food and Drug Administration has concluded that the inspection of a single site in its TRANQUILITY II Phase 3 trial is closed under 21 C.F.R.20. ...

In the rhetoric of partisan politics surrounding the three language formula, unsurprisingly, the most important stakeholder has been forgotten: the student. First, it is the child who goes to a ...

The British Big Pharma has filed depemokimab for FDA approval in two respiratory indications on the back of new phase 3 data showing the antibody improved disease symptoms and quality of life in ...

The phase 3 VERIFY study (NCT05210790) demonstrated that rusfertide (PTG-300), a hepcidin mimetic, significantly outperformed placebo in achieving clinical response among phlebotomy-dependent patients ...

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) today announced positive topline results for the Phase 3 ...